Alphatec Touts 2026 Growth Plan at JPMorgan Conference, Guides to $890M Revenue and $20M FCF

Executives from Alphatec (NASDAQ:ATEC) outlined the company’s strategy for “long-term differentiated growth” during a presentation at a JPMorgan healthcare conference, highlighting recent financial performance, a continued emphasis on procedure-focused product design, and an expanding role for data